Skip to main content

Table 3 Correlation between SPHK1 expression and clinicopathologic characteristics of SGC

From: Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

Characteristics SPHK1 Chi-square test P-value
   Low or none No. cases (%) High No. cases (%)  
Gender Male 45 (67.2) 44 (47.8) 0.150
  Female 22 (32.8) 48 (52.2)  
Age (years) ≥ 47 34 (50.7) 47 (51.1) 0.966
  < 47 33 (49.3) 45 (48.9)  
Clinical Stage I 10 (13.5) 6 (7.1) 0.005
  II 35 (47.3) 23 (27.1)  
  III 16 (21.6) 23 (27.1)  
  IV 13 (17.6) 33 (38.8)  
T classification T1 10 (13.5) 7 (8.2) 0.017
  T2 40 (54.1) 32 (37.6)  
  T3 16 (21.6) 21 (24.7)  
  T4 8 (10.8) 25 (29.4)  
N classification N0 60 (81.1) 58 (68.2) 0.009
  N1 9 (12.2) 12 (14.1)  
  N2 5 (6.8) 15 (17.6)  
  N3 0 (0.0) 0 (0.0)  
M classification No 61 (80.6) 52 (64.1) 0.002
  Yes 13 (19.4) 33 (35.9)  
Pathologic Differentiation Poor 57(35.8) 44(27.7) 0.013
  Moderate 4(2.5) 0(0.0)  
  Well 24(15.1) 30(18.9)  
Histological Types MEC 15(20.3) 22(25.9) 0.945
  ACC 11(14.9) 12(14.1)  
  AcCC 9(12.2) 9(10.6)  
  SDC 9(12.2) 9(10.6)  
  Other histological types 30(40.5) 33(38.8)